STREAM is the first large-scale, multi-country clinical trial to investigate shortened regimens for multidrug-resistant TB (MDR-TB), and the first phase III trial to test the efficacy and safety of bedaquiline, a new drug with a novel mechanism of action, within a shortened treatment regimen.
The trial established a Community Engagement (CE) Plan. The CE program was implemented at 13 research sites within the STREAM trial, in seven countries. A document sets out a summary of the experiences of the Community Advisory Boards (CABs) in connection with the STREAM clinical trial. It underlines relevant aspects that may be useful when planning and/or engaging communities in research. In conclusion, the experiences gained during STREAM, lead to both growing confidence in CE as a valuable process and community participation in advocacy.
The document analyses qualitative data gathered from a consultation organized in collaboration with all the 13 STREAM CABs in the seven countries, which answered dedicated questions developed for this purpose on the Survey Monkey platform as well as quarterly CABs reports, trainings and All-STREAM CABs’ webinars notes.
To access the document, Community engagement lessons learned: A community perspective, click here.
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.